Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Publication Date timeline is not available.
Page 1
Doublet and Triplet Combinations of Eribulin, Fulvestrant, and Palbociclib in Preclinical Breast Cancer Models.
Anticancer Res. 2024 Jan;44(1):61-70. doi: 10.21873/anticanres.16788.
Anticancer Res. 2024.
PMID: 38160008
Liposomal Irinotecan Shows a Larger Therapeutic Index than Non-liposomal Irinotecan in Patient-Derived Xenograft Models of Pancreatic Cancer.
Barbier S, Beaufils B, de Miguel R, Reyre M, Le Meitour Y, Lortie A, de Boisferon MH, Chaumeron S, Espirito A, Fossati L, Lagarde P, Klinz S, Thiagalingam A, Lezmi S, Meyer-Losic F.
Barbier S, et al. Among authors: de boisferon mh.
Oncol Ther. 2023 Mar;11(1):111-128. doi: 10.1007/s40487-022-00215-2. Epub 2023 Jan 16.
Oncol Ther. 2023.
PMID: 36645622
Free PMC article.
Item in Clipboard
Broad-spectrum Preclinical Antitumor Activity of Eribulin (Halaven®): Combination with Anticancer Agents of Differing Mechanisms.
Asano M, Matsui J, Towle MJ, Wu J, McGonigle S, DE Boisferon MH, Uenaka T, Nomoto K, Littlefield BA.
Asano M, et al. Among authors: de boisferon mh.
Anticancer Res. 2018 Jun;38(6):3375-3385. doi: 10.21873/anticanres.12604.
Anticancer Res. 2018.
PMID: 29848686
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.